医学
糖尿病
糖尿病肾病
糖尿病性视网膜病变
氧化应激
胰岛素抵抗
血糖
肾病
视网膜病变
药理学
糖尿病神经病变
新生血管
内科学
血管生成
生物信息学
内分泌学
生物
作者
Liangzhen You,Yixuan Lin,Zhaohui Fang,Guo-Ming Shen,Jindong Zhao,Tingting Wang
出处
期刊:PubMed
日期:2017-12-01
卷期号:42 (24): 4700-4706
被引量:18
标识
DOI:10.19540/j.cnki.cjcmm.20171010.007
摘要
Diabetes has become a global public health problem that seriously threatens human health. Traditional Chinese medicine, the characteristics of the role of multiple targets, has a unique advantage in the prevention and treatment of diabetes mellitus and its complications. Astragaloside-Ⅳ (AS-Ⅳ), one of the main activities of Astragalus membranaceus, has a series of pharmacological effects including improvement in the function of endothelial cells and neovascularization, anti-inflammatory, antioxidant, regulating energy metabolism, protectionnervous, anti-cancer and so on. In this paper, AS-Ⅳ to prevent and treat diabetes and its complications has been reviewed, which has effect on lowering blood sugar, lowering blood pressure, improving insulin resistance, inhibiting inflammatory reaction and oxidative stress. Additionally, it also can improve the diabetic animal and cell model of diabetic vascular disease, diabetic nephropathy, diabetic retinopathy, diabetic peripheral neuropathy, diabetic cardiomyopathy and other pathological damages. AS-Ⅳ may be a potential active substance for the treatment of diabetes and its complications.
科研通智能强力驱动
Strongly Powered by AbleSci AI